Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

3,140.00p
   
  • Change Today:
    -20.00p
  • 52 Week High: 3,175.00
  • 52 Week Low: 1,548.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 175,478
  • Market Cap: £2,089.29m
  • RiskGrade: 128
  • Beta: 0.71

Latest ShareCast News

Genus hails successful formation of Chinese porcine JV

By Michele Maatouk

Date: Monday 02 Feb 2026

(Sharecast News) - Animal genetics firm Genus said on Monday that it successfully formed its Chinese porcine joint venture on 31 January.

Genus Regulatory News

Successful formation of Chinese porcine JV 02-Feb-2026 07:00 RNS
PRP Regulatory Progress – Canada 23-Jan-2026 17:23 RNS
Half Year Trading Update – Ahead of expect... 16-Jan-2026 07:00 RNS
Director/PDMR Shareholding 27-Nov-2025 07:00 RNS
Results of AGM 19-Nov-2025 12:12 RNS

Genus News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 3,140.00p
Change Today -20.00p
% Change -0.63 %
52 Week High 3,175.00
52 Week Low 1,548.00
Volume 175,478
Shares Issued 66.54m
Market Cap £2,089.29m
Beta 0.71
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 2
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 02-Feb-2026

Time Volume / Share Price
10:23 100 @ 3,135.00p
10:23 100 @ 3,135.00p
10:23 100 @ 3,135.00p
10:20 28 @ 3,140.00p
10:20 8 @ 3,140.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page